newsfilter
← Latest News
GlobeNewswire·

Clearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, Supporting Enhanced Nasal Retention Without Compromising Drug Delivery

Vancouver, Canada, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND, FSE: CWY0)) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and